Consumer-Driven Future of GLP-1s: Apps & Social Media
Explore how social media trends and digital health apps are transforming access to GLP-1 medications in Canada, moving beyond traditional healthcare channels.
Category : Search result: weight gain for role
Blue Bombers' Jake Thomas moves from player to coach
Longtime Winnipeg Blue Bombers defensive lineman Jake Thomas ends his playing career, signing a one-year deal to join the team's coaching staff. A veteran leader transitions to a new role.
Novo Nordisk shares jump 8% on U.S. Wegovy pill approval
Shares of Novo Nordisk surged nearly 8% after the U.S. FDA approved its Wegovy weight-loss pill. The landmark decision marks a major expansion for the obesity drug market.
U.S. Approves Pill Version of Popular Weight-Loss Drug
U.S. regulators have greenlit a pill version of a leading weight-loss medication, potentially broadening treatment options. Learn about the approval and its implications.
FDA Approves Wegovy Weight Loss Pill
U.S. regulators have approved the Wegovy pill for weight loss, a major development in pharmaceutical treatment. Learn about the details and potential impact of this new drug.
Egypt's el-Sissi Urges UN Reforms for Africa's Larger Role
Egyptian President Abdel-Fattah el-Sissi calls for urgent UN Security Council reforms to give Africa a more significant voice in global affairs. Read the full story on the push for international governance change.
Lilly pill keeps weight off after injectable drugs in trial
New data shows Eli Lilly's oral weight-loss drug successfully maintains weight reduction after patients switch from injectable medications. A breakthrough for chronic obesity management.
Weight Watchers Unveils New Platform for GLP-1 Era
Weight Watchers launches a fully integrated digital platform offering comprehensive support for members using GLP-1 medications, featuring personalized nutrition, coaching, and community. Discover the future of weight management.
New Brunswickers back greater paramedic role: poll
A new poll reveals strong public support in New Brunswick for paramedics to take on a larger role in the healthcare system. Discover the details and what it means for the future of care.
GLP-1 Drugs Like Ozempic Threaten Fast-Food Business
Experts warn injectable weight-loss drugs such as Ozempic are reducing consumer appetites, posing a significant challenge to the fast-food sector's traditional business model in Canada.
Meet Tanice: Toronto Sun's SUNshine Girl Entrepreneur
Discover Tanice, the Toronto Sun's latest SUNshine Girl - a model and entrepreneur balancing garden maintenance with fitness passions. Learn her inspiring story today!
Novo's obesity drug shows 14.5% weight loss in trial
Novo Nordisk's experimental obesity drug amycretin demonstrates significant weight loss results in mid-stage study, advancing to late-phase testing for diabetes patients.
Novo Nordisk Alzheimer's Drug Trials Fail
Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.
Eli Lilly Reaches $1 Trillion Valuation Milestone
Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.
Jelly Roll Unrecognizable After 200-Pound Weight Loss Journey
Country superstar Jelly Roll reveals dramatic new look after shaving beard for first time in decade following 200-pound natural weight loss transformation.
Ozempic Reshapes Canada's Food Economy: $3.3B Impact
Two million Canadians using GLP-1 drugs like Ozempic are dramatically changing food consumption patterns, removing $3.3 billion annually from Canada's food economy. Learn how this trend affects groceries, restaurants and agriculture.
Meghan Trainor responds to skinny-shaming with new song
Meghan Trainor reveals how negative comments about her weight loss inspired her new single 'Still Don't Care.' The singer opens up about her health journey and body image struggles.
Novo Nordisk rolls out $349 Wegovy cash price early
Novo Nordisk introduces $349 cash price for Wegovy weight-loss drug ahead of schedule. Learn how this affects Canadian healthcare access and affordability.
Sydney Sweeney gains 35 pounds for boxing role
Actress Sydney Sweeney discusses her dramatic 35-pound weight gain to portray boxer Christy Martin in a new biopic, while also addressing recent controversies.
GLP-1 Drugs and Hair Loss: What You Need to Know
Discover why some patients experience hair loss while taking GLP-1 medications like Ozempic. Learn about the science behind this side effect and expert recommendations.
Quebec man extradited for $1.8M weight-loss scam
Supreme Court refuses appeal for Quebec man accused of $1.8 million weight-loss fraud. Extradition to U.S. proceeds in international scam case. Read the full details.
Ozempic Penis: The Truth Behind Viral Claim
Discover the truth about 'Ozempic penis' - the viral claim about GLP-1 medications. Urologists explain why it's an optical illusion and reveal real sexual side effects.
Michelle Obama Slams Trump's White House Renovation
Michelle Obama denounced Donald Trump's East Wing demolition, calling it a reflection of his view on the First Lady's role. Learn more about the political symbolism.
Gordon Ramsay's fiery rejection of weight-loss drug menus
Celebrity chef Gordon Ramsay refuses to create menus for diners on weight-loss drugs like Ozempic, sparking debate. Discover his controversial stance and its potential impact.
Pfizer wins $10B obesity drug takeover battle
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Trump's Plan to Slash Obesity Drug Prices
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
Trump Reveals Deal to Lower Obesity Drug Costs
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Trump Obesity Drug Deal Boosts Pharma Stocks
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Canada Eyes Post-War Role in Gaza Strip
Global Affairs Canada confirms exploring potential postwar involvement in Gaza Strip reconstruction and security. Exclusive details on Canada's emerging Middle East strategy.
Bob Rae Leaves UN Role With No Regrets
Former Canadian ambassador Bob Rae concludes his United Nations tenure, sharing insights on global diplomacy and future plans in exclusive interview.
Page 1 of 2